Company Profile - 10X Genomics Inc

Introduction

10X Genomics Inc (10X Genomics) is engaged in developing an innovative genomics platform. The company’s product pipeline comprises chromium X series, chromium connect, and chromium controller. It offers services such as single-cell gene expression, single-cell immune profiling, fixed RNA profiling, single-cell multiome ATAC + gene expression, spatial gene expression, and targeted gene expression. The company also provides Barcode technology which is compatible with Single Cell Gene Expression and Immune Profiling solutions allowing researchers to simultaneously measure multiple analytes, such as protein and RNA, within the same set of cells or tissues. The company has operations in the US, North America, Europe, and Asia. 10X Genomics is headquartered in Pleasanton, California, the US.

Company info

Country (HQ): United States
Sector: Medical Equipment
Market Cap (US$ m): 6,105
Revenue (US$ m): 516 (2022)

Innovation ranking

508

Innovation score

Closest peers in the Medical Equipment sector

Innovation Ranking

Company
Headquarters
Sector

Medtronic Plc

Ireland

Medical Equipment

Boston Scientific Corp

United States

Medical Equipment

10X Genomics Inc

United States

Medical Equipment

Savara Inc

United States

Medical Equipment

Aethlon Medical Inc

United States

Medical Equipment

Are you ranked? Get the Innovation Ranking Report

  • Company Ranking Report
    • If your company is ranked you can get more detailed information about your ranking through the Innovation Ranking Report
    • Full company scorecard across the 3 pillars and 19 data indicators that make up the ranking score
    • Contextualised information on the company's standing in relation to peers
    • Key takeaways on the company's position in its sector, country and its standing in relation to key industry themes
    • Tips on how to use your ranking to tell a unique and compelling story in your marketing, benchmarking and hiring processes
  • Rosettes
  • Certificate of Achievement
  • Press release
Screenshot of Deal Makers